Fiveable

💊Pharmacology for Nurses Unit 6 Review

QR code for Pharmacology for Nurses practice questions

6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs

6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs

Written by the Fiveable Content Team • Last updated August 2025
Written by the Fiveable Content Team • Last updated August 2025
💊Pharmacology for Nurses
Unit & Topic Study Guides

Overview of Inflammation

Process of inflammation

Inflammation is the body's built-in defense system. When tissue is damaged or a pathogen invades, the immune system launches a coordinated response involving immune cells, blood vessels, and chemical mediators. The goal is to contain the threat, clear out damaged cells, and start the healing process.

There are two main forms:

  • Acute inflammation is a rapid, short-term response triggered by tissue damage or pathogen invasion. Blood flow increases to the area, blood vessels become more permeable, and immune cells (especially neutrophils) flood in. This is the redness and swelling you see around a fresh cut or sprained ankle.
  • Chronic inflammation develops when acute inflammation fails to resolve, or when the body faces a persistent stimulus (like an autoimmune condition). Over time, this leads to tissue destruction, fibrosis (scarring), and impaired healing. Conditions like rheumatoid arthritis and Crohn's disease involve chronic inflammation.

Cardinal signs of inflammation

These five classic signs show up on exams constantly. Know the Latin terms and what causes each one:

  • Redness (rubor) results from vasodilation and increased blood flow (hyperemia) to the affected area.
  • Swelling (tumor) occurs because increased vascular permeability allows fluid and proteins to leak into surrounding tissues, causing edema.
  • Heat (calor) comes from increased blood flow and the metabolic activity of immune cells at the site.
  • Pain (dolor) is triggered by chemical mediators (like bradykinin and prostaglandins) stimulating nerve endings, plus physical pressure from swelling.
  • Loss of function (functio laesa) results from the combination of tissue damage, swelling, and pain limiting normal use of the affected area.

Causes and diagnosis of inflammation

Inflammation can be triggered by a wide range of insults:

  • Infections: bacterial, viral, fungal, or parasitic
  • Physical injuries: trauma, burns, frostbite
  • Chemical irritants: toxins, allergens, acids
  • Autoimmune disorders: rheumatoid arthritis, systemic lupus erythematosus

To diagnose and monitor inflammation, clinicians use several tools:

  • Physical examination to assess the cardinal signs
  • Blood tests, particularly erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), both of which rise during active inflammation
  • Imaging studies (X-rays, CT scans, MRI) to visualize tissue changes
  • Tissue biopsy for histological examination when the cause is unclear

Inflammatory mediators and responses

Understanding the key chemical mediators helps you see how anti-inflammatory drugs work, since most of them target one or more of these pathways.

  • Cytokines and chemokines are signaling proteins released by immune cells. Cytokines (like TNF-alpha and interleukins) regulate the intensity of the response, while chemokines recruit more immune cells to the site.
  • The complement system is a cascade of plasma proteins that enhances the immune response by promoting pathogen clearance, triggering inflammation, and forming membrane attack complexes.
  • Arachidonic acid and eicosanoids are especially important for pharmacology. When cell membranes are damaged, phospholipase A2 releases arachidonic acid. Enzymes then convert it into eicosanoids, including prostaglandins (which cause pain, fever, and vasodilation) and leukotrienes (which increase vascular permeability and attract immune cells). This is the pathway that NSAIDs and corticosteroids target.
  • The acute phase response is a systemic reaction involving fever, elevated production of acute phase proteins (like CRP and fibrinogen), and metabolic changes across multiple organ systems.
Process of inflammation, Frontiers | The Roles of Inflammation in Keloid and Hypertrophic Scars

Anti-inflammatory Drugs

Characteristics of anti-inflammatory drugs

Anti-inflammatory drugs reduce inflammation by blocking the production or activity of inflammatory mediators, particularly prostaglandins and leukotrienes. The result is less pain, less swelling, and reduced fever.

The three major classes you need to know:

  • NSAIDs (Non-steroidal anti-inflammatory drugs): ibuprofen, naproxen, aspirin
  • Corticosteroids: prednisone, dexamethasone
  • DMARDs (Disease-modifying anti-rheumatic drugs): methotrexate, sulfasalazine

Each class works at a different point in the inflammatory pathway, which explains their different side effect profiles and clinical uses.

Comparison of anti-inflammatory medications

NSAIDs

  • Mechanism: Inhibit cyclooxygenase (COX) enzymes (COX-1 and COX-2), which blocks the conversion of arachidonic acid into prostaglandins. COX-1 is constitutive (always active, protects the stomach lining and supports platelet function), while COX-2 is induced at sites of inflammation. Most traditional NSAIDs block both.
  • Side effects: GI irritation and ulceration (because blocking COX-1 reduces the protective stomach mucus), increased cardiovascular risk with prolonged use, and renal impairment (prostaglandins help maintain renal blood flow).
  • Key interactions: Anticoagulants (increased bleeding risk), antihypertensives (NSAIDs can raise blood pressure by promoting sodium retention), lithium (NSAIDs reduce lithium excretion, raising levels).

Corticosteroids

  • Mechanism: These are the most potent anti-inflammatory agents. They inhibit phospholipase A2, which prevents the release of arachidonic acid altogether. This means they block both prostaglandin and leukotriene production. They also broadly suppress the immune response by reducing cytokine production and immune cell activity.
  • Side effects: Hyperglycemia, osteoporosis, adrenal suppression (the adrenal glands stop producing cortisol naturally with prolonged use), immunosuppression, weight gain, and mood changes.
  • Key interactions: NSAIDs (compounded GI risk), oral contraceptives (altered steroid metabolism), anticoagulants (altered clotting response).

Nursing alert: Corticosteroids should never be stopped abruptly after prolonged use. Tapering is required to allow the adrenal glands to resume normal cortisol production. Abrupt discontinuation can cause adrenal crisis.

DMARDs

  • Mechanism: Unlike NSAIDs and corticosteroids, DMARDs don't just treat symptoms. They modify the underlying disease process, slowing joint destruction in conditions like rheumatoid arthritis. Methotrexate, for example, inhibits immune cell proliferation.
  • Side effects: Hepatotoxicity, bone marrow suppression (leading to pancytopenia), and pulmonary fibrosis with long-term use.
  • Key interactions: NSAIDs (increased methotrexate toxicity due to reduced renal clearance), other immunosuppressants (additive immunosuppression), live vaccines (risk of vaccine-induced infection in immunosuppressed patients).

Nursing considerations for anti-inflammatories

Assessment

  • Evaluate the patient's baseline condition, including the reason for anti-inflammatory therapy, current pain level, and location/severity of inflammation.
  • Review the patient's history for contraindications: GI ulcers (NSAIDs), diabetes (corticosteroids), liver disease (DMARDs).
  • Obtain baseline vital signs.

Dosage and administration

  • Follow prescribed dosing regimens and routes. NSAIDs should generally be taken with food to reduce GI irritation.
  • Adjust dosage based on patient response and the emergence of adverse effects.
  • For corticosteroids, administer in the morning when possible to mimic the body's natural cortisol rhythm.

Monitoring

  • Assess for therapeutic response: Is pain decreasing? Is swelling resolving?
  • Watch for adverse effects specific to each drug class (GI bleeding with NSAIDs, blood glucose elevation with corticosteroids, CBC changes with DMARDs).
  • Order and track regular lab work: liver function tests, renal function tests, and complete blood counts, especially for patients on DMARDs or long-term corticosteroid therapy.

Patient education for anti-inflammatory use

Medication information

  • Explain the purpose and expected benefits of the prescribed drug, including how long it typically takes to work. (NSAIDs provide relatively quick relief; DMARDs may take weeks to months.)
  • Review proper dosing, timing, and route. Emphasize not exceeding recommended NSAID doses, as higher doses increase side effect risk without proportionally increasing benefit.
  • Teach patients which side effects to report immediately: black or tarry stools (GI bleeding), unusual bruising (bone marrow suppression), signs of infection (immunosuppression).

Lifestyle modifications

  • Encourage a diet rich in anti-inflammatory foods: fruits, vegetables, and omega-3 fatty acids (found in fatty fish, flaxseed, and walnuts).
  • Promote regular physical activity appropriate to the patient's condition.
  • Discuss stress management techniques, since chronic stress can worsen inflammatory conditions.

Non-pharmacological interventions

  • Heat therapy can help with chronic stiffness; cold therapy works better for acute swelling.
  • Recommend assistive devices or orthotics for patients with joint involvement.
  • Educate on proper body mechanics and joint protection strategies to reduce strain.

Follow-up and monitoring

  • Schedule regular check-ups to evaluate treatment response and adjust therapy.
  • Encourage patients to keep a symptom diary tracking pain levels, medication use, and any new symptoms.
  • Provide reliable resources for additional support (e.g., the Arthritis Foundation for patients with rheumatic conditions).